Digestive Diseases and Sciences

, Volume 39, Issue 12, pp 2589–2594 | Cite as

Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients

  • A. Belluzzi
  • C. Brignola
  • M. Campieri
  • E. P. Camporesi
  • P. Gionchetti
  • F. Rizzello
  • C. Belloli
  • G. De Simone
  • S. Boschi
  • M. Miglioli
  • L. Barbara
Intestinal Disorders, Inflammatory Bowel Disease, Immunology, And Microbiology

Abstract

Fish oil has been recently proposed as a possible effective treatment in inflammatory bowel disease (IBD); however, a lot of annoying side effects (ie, belching, halitosis, diarrhea, etc) affect patient compliance. We carried out a study of patient tolerance in a group of Crohn's disease (CD) patients with a new fish oil derivative consisting of 500-mg capsules of eicosapentaenoic-docosahexaenoic (EPA 40%-DHA 20%), a free fatty acid mixture (Purepa), and we also evaluated its incorporation into phospholipids, both in plasma and in red cell membranes. Five groups of 10 CD patients in remission received nine Purepa capsules daily in four different preparations (A: uncoated, B: coated, pH 5.5; C: coated, pH 5.5, 60 min time release; D: coated, pH 6.9) and 12 × 1-g capsules daily of a triglyceride preparation (Max-EPA, EPA 18%-DHA 10%), respectively. We coated three of the four Purepa preparations in order to delay the release of contents in an attempt to minimize the side effects. After six weeks of treatment, the group taking Purepa capsules, coated, pH 5.5, 60 min time release (group C) showed the best incorporation of EPA and DHA in red blood cell phospholipid membranes (EPA from 0.2 to 4.4%, DHA from 3.7 to 6.3%), and no side effects were registered, whereas in all other groups side effects were experienced in 50% or more of subjects. This new preparation will make it possible to treat patients for long periods.

Key words

Crohn's disease fish oil 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Leaf A, Weber P: Cardiovascular effects of dietary omega-3 fatty acids N Engl J Med 318:549–557, 1988PubMedGoogle Scholar
  2. 2.
    Kremer JM, Jubiz W, Michalek A, Rynes RI, Bartholomew LE, Bigaoette J, Timchalk M, Beeler D, Lininger L: Fish oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. Ann Intern Med 106:497–503, 1987PubMedGoogle Scholar
  3. 3.
    Bittiner SB, Tucker WF, Cartwright I, Bleehen SS: A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet i:378–380, 1988Google Scholar
  4. 4.
    Lee TH, Hoover RL, Williams D, Sperling RI, Ravalese J, Hoover RL, Mouse F, Coblyn JS, Fraser PA, Spur BW, Robinson DR, Lewis RA, Austen KF: Effect of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acids onin vitro polymorphonuclear and monocyte leukotriene generation and polymorphonuclear leukocyte function. N Engl J Med 312:1217–1224, 1985PubMedGoogle Scholar
  5. 5.
    Ford-Hutchinson AW: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leucocytes. Nature 286:264–265, 1980PubMedGoogle Scholar
  6. 6.
    Von Schacky C, Fisher S, Weber PC: Long-term effects of dietary marine n-3 fatty acids upon plasma and cellular lipids, platelet function and eicosanoid formation in humans. J Clin Invest 76:1626–1631, 1985PubMedGoogle Scholar
  7. 7.
    Strasser T, Fisher S, Weber PC: Leukotriene B5 is formed in human neutrophils after dietary supplementation with eicosapentaenoic acid. Proc Natl Acad Sci USA 82:1540–1543, 1985PubMedGoogle Scholar
  8. 8.
    Weber PC: The modification of the arachidonic acid cascade by n-3 fatty acids. Adv Prostaglandin Thromboxane Leukotriene Res 20:232–240, 1990Google Scholar
  9. 9.
    Sinclair HM: The diet of Canadian Indians and Eskimos. Proc Nutr Soc 12(1):69, 1953Google Scholar
  10. 10.
    Tobin A: Fish oil supplementation in pregnancy. Lancet 340:118, 1992Google Scholar
  11. 11.
    O'Connors GT, Malenka DJ, Olmstead EM, Johnson PS, Hennekens CH: A metaanalysis of randomized trials of fish oil in prevention of restenosis following coronary angioplasty. Am J Prev Med 8(3):186–192, 1992PubMedGoogle Scholar
  12. 12.
    Olsen SF, Sorensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS, Grant A: Randomised controlled trial of fish oil supplementation on pregnancy duration. Lancet 339:1003–1007, 1992PubMedGoogle Scholar
  13. 13.
    El Boustani S, Colette C, Monnier L, Descomps B, Crastes de Paulet A, Mendy F: Enteral Absorption in man of eicosapentaenoic acid in different chemical forms. Lipids 22:711–714, 1987PubMedGoogle Scholar
  14. 14.
    Lawson LD, Hughes BG: Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem Biophys Res Commun 152:328–335, 1988PubMedGoogle Scholar
  15. 15.
    Von Schacky C, Weber PC: Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 76:2446–2450, 1985PubMedGoogle Scholar
  16. 16.
    Salomon P, Kornbluth AA, Janowitz HD: Treatment of ulcerative colitis with fish oil n-3-w-fatty acid: An open trial. J Clin Gastroenterol 12(2):157–161, 1990PubMedGoogle Scholar
  17. 17.
    Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL, Beeken W: Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116:609–614, 1992PubMedGoogle Scholar
  18. 18.
    McCall TB, O'Learly D, Bloomfield J, O'Morain CA: Therapeutic potential of fish oil in the treatment of ulcerative colitis. Aliment Pharmacol Ther 3(5):415–424, 1989PubMedGoogle Scholar
  19. 19.
    Best WR, Becltel JM, Singleton JW, Kern F: Develpoment of a Crohn's disease activity index (National Cooperative Crohn's Disease Study). Gastroenterology 70:439–444, 1976PubMedGoogle Scholar
  20. 20.
    Brignola C, Campieri M, Bazzocchi G, Farruggia P, Tragnone A, Lanfranchi GA: A laboratory index for predicting relapse in asynmptomatic patients with Crohn's disease. Gastroenterology 91:1490–1494, 1986PubMedGoogle Scholar
  21. 21.
    Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD: Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29:1035–1041, 1988PubMedGoogle Scholar
  22. 22.
    Popp-Snijders C, Schouten A, De Jong AP, Van Der Veen EA: Effect of dietary cod-liver oil on the lipid composition of human erythrocyte membranes. Scand J Clin Lab Invest 44:39–46, 1984PubMedGoogle Scholar
  23. 23.
    Dodge JT, Phillips GB: Composition of phospholipids and phospholipid fatty acids and aldehydes in human red cells. J Lipids Res 8:667–675, 1967Google Scholar
  24. 24.
    Rouser G, Kritcheusky G, Yamamoto A:In Lipid Chromatographic Analysis: Chromatography of Common and Uncommon Lipid Classes. GV Marinetti, New York, Marcel Dekker, 1967, p 99Google Scholar
  25. 25.
    Morrison WR, Smith LM: Preparation of fatty acids methyl esters and dimethylacetals. J Lipids Res 5:600–608, 1964Google Scholar
  26. 26.
    Galloway JH, Cartwright IJ, Woodcock BE, Greaves M, Russel RGG, Preston FE: Effects of dietary fish oil supplementation on the fatty acid composition of the human platelet membrane: demonstration of selectivity in the incorporation of eicosapentaenoic acid into membrane phospholipid pools. Clin Sci 68:449–454, 1985PubMedGoogle Scholar
  27. 27.
    Hawthorne AB, Daneshmend TK, Hawkey CJ, Belluzzi A, Everitt SJ, Holmes GKT, Halkinson C, Shaheen MZ, Willars JE: Treatment of ulcerative colitis with fish oil supplementation: A prospective 12 month randomised controlled trial. Gut 33:922–928, 1992PubMedGoogle Scholar
  28. 28.
    Terano T, Hirai A, Hamazaki T, Kobayashi S, Fyjita T, Tamura Y, Kumagaf A: Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 46:321–331, 1983PubMedGoogle Scholar
  29. 29.
    Belluzzi A, Hawthorne AB, Hawkey CJ: Increased neutrophil membrane w-3 fatty acids may be of clinical benefit in patients with ulcerative colitis. Gut A-1501–A-1502, 1989 (abstract)Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • A. Belluzzi
    • 1
  • C. Brignola
    • 1
  • M. Campieri
    • 1
  • E. P. Camporesi
    • 1
  • P. Gionchetti
    • 1
  • F. Rizzello
    • 1
  • C. Belloli
    • 1
  • G. De Simone
    • 1
  • S. Boschi
    • 1
  • M. Miglioli
    • 1
  • L. Barbara
    • 1
  1. 1.From the Istituto di Clinica Medica e Gastroenterologia, Cattedra di Medicina, d'Urgenza, Servizio di Farmacologia ClinicaBolognaItaly

Personalised recommendations